BHC
BMY icon

Bull Harbor Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bull Harbor Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.77M Buy
65,358
+4,038
+7% +$232K 0.73% 18
2026
Q1 		$3.72M Buy
+61,320
New +$3.57M 1% 9

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bull Harbor Capital's BMY Position: Q2 2026 in Review

Bull Harbor Capital increased its Bristol-Myers Squibb (BMY) stake by 6.6% in Q2 2026, buying an estimated $232K and bringing the position to 65,358 shares worth $3.77M. The position accounts for 0.73% of the portfolio, ranked #18.

Bull Harbor Capital first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Bull Harbor Capital held 65,358 shares of Bristol-Myers Squibb worth $3.77M as of Q2 2026.
  • Bull Harbor Capital bought 4,038 Bristol-Myers Squibb shares in Q2 2026, an estimated $232K.
  • Bristol-Myers Squibb made up 0.73% of Bull Harbor Capital's portfolio in Q2 2026, its #18 holding.
  • Bull Harbor Capital first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
  • 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bull Harbor Capital's 13F filing for Q2 2026, filed 10 Aug 2026.